[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the β‑actin control bands shown in Fig. 6D on p. 25 had already been submitted for publication to a different journal in an article written by different authors at different research institutes. In addition, it was also identified that invasion assay data in Fig. 4D and western blot data in Fig. 5E also subsequently appeared in articles in other journals that were written by different authors at different research institutes. Given that the abovementioned contentious data in Fig. 6D had already been submitted for publication elsewhere prior to the submission of this paper to <i>International Journal of Oncology</i>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 54: 17‑28, 2019; DOI: 10.3892/ijo.2018.4600].

Authors

Institutions

Publication Details

Journal
International Journal of Oncology
Published
2026-02-24
DOI
https://doi.org/10.3892/ijo.2026.5862
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis

Guangchao Duan, Chao Xu, Changke Xu, Lei Zhang et al.
International Journal of Oncology
MicroRNA in disease regulation
article

[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis

Guangchao Duan, Chao Xu, Changke Xu, Lei Zhang, Chuanlin Zhang, Yan Zhang
article en

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the β‑actin control bands shown in Fig. 6D on p. 25 had already been submitted for publication to a different journal in an article written by different authors at different research institutes. In addition, it was also identified that invasion assay data in Fig. 4D and western blot data in Fig. 5E also subsequently appeared in articles in other journals that were written by different authors at different research institutes. Given that the abovementioned contentious data in Fig. 6D had already been submitted for publication elsewhere prior to the submission of this paper to <i>International Journal of Oncology</i>, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [International Journal of Oncology 54: 17‑28, 2019; DOI: 10.3892/ijo.2018.4600].

International Journal of OncologyVol. 68(5)
Shangqiu First People's Hospital (CN)
Zero hunger
Openalex Percentile: Top 43%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.